All the News in one place from Singapore
More than 50 news sites, more than 1000 pieces of news daily
Singapore's Juniper Biologics secures $600 million licensing deal from Kolon to commercialize cell-mediated gene therapy for degenerative arthritis.
(April 14 05:17) World.einnews.com
… -- Juniper Biologics, a Singapore-based developer of novel therapies, has secured … -sok. TG-C is a novel cell and gene therapy targeting …
Share Singapore's Juniper Biologics secures $600 million licensing deal from Kolon to commercialize cell-mediated gene therapy for degenerative arthritis. on your favourite social media